402 related articles for article (PubMed ID: 30538665)
1. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
2. Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu Q; Liu S; Zhang P; Wang Z; Chang X; Liu Y; Yan J; He R; Luo X; Zou LY; Chu X; Guo Y; Huang S; Fu X; Huang Y
Front Immunol; 2021; 12():759187. PubMed ID: 34675937
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
4. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
5. Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
Santoro D; Debiec H; Longhitano E; Torreggiani M; Barreca A; Vegezzi E; Mazzeo A; Russo M; Piccoli GB; Toscano A; Ronco P
Am J Kidney Dis; 2022 Aug; 80(2):289-294. PubMed ID: 34762973
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
9. Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies.
Shida R; Iwakura T; Ohashi N; Ema C; Aoki T; Tashiro T; Ishigaki S; Isobe S; Fujikura T; Kato A; Nakamura T; Fujigaki Y; Shimizu A; Yasuda H
Intern Med; 2024; 63(5):699-705. PubMed ID: 38432895
[TBL] [Abstract][Full Text] [Related]
10. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
11. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.
Ogata H; Yamasaki R; Hiwatashi A; Oka N; Kawamura N; Matsuse D; Kuwahara M; Suzuki H; Kusunoki S; Fujimoto Y; Ikezoe K; Kishida H; Tanaka F; Matsushita T; Murai H; Kira J
Ann Clin Transl Neurol; 2015 Oct; 2(10):960-71. PubMed ID: 26478896
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
13. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
[TBL] [Abstract][Full Text] [Related]
15. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
16. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
17. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
[TBL] [Abstract][Full Text] [Related]
19. Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy.
Le Quintrec M; Teisseyre M; Bec N; Delmont E; Szwarc I; Perrochia H; Machet MC; Chauvin A; Mavroudakis N; Taieb G; Lanfranco L; Rigothier C; José B; Concetta C; Geneste C; Pernin V; Larroque C; Devaux J; Beyze A
Kidney Int; 2021 Dec; 100(6):1240-1249. PubMed ID: 34600965
[TBL] [Abstract][Full Text] [Related]
20. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
